PDL BioPharma has appointed Edward Imbrogno as vice president of Finance, a new position.  

Mr. Imbrogno brings to PDL more than 30 years of public accounting and financial reporting experience and will report to vice president and chief financial officer, Peter Garcia.  

“Ed’s significant experience in developing internal controls for new business growth, with responsibility for SEC reporting and audit management, makes him an excellent addition to our team,” said Garcia.  “His work in structuring mergers and acquisitions, and in post-acquisition accounting will be tremendous assets as we execute on our business strategy of acquiring and managing a portfolio of companies, products and royalty agreements in the biopharmaceutical and medical device industries.”

Most recently, Mr. Imbrogno was senior director and corporate controller for BioDelivery Sciences International.